ASX:IMMPharmaceuticals, Biotechnology & Life SciencesBiotechnology
IMMUTEP ORD
$0.050
$0.001 (1.96%)
Day Range
$0.049 - $0.053
52 Week Range
$0.028 - $0.470
Volume
28.76M
Avg Volume (10D)
88.99M
Market Cap
$73.69M
Price Chart
Market Statistics
Open$0.051
Previous Close$0.051
Day High$0.053
Day Low$0.049
52 Week High$0.470
52 Week Low$0.028
Valuation
Market Cap73.69M
Shares Outstanding1.47B
Price to Book0.76
Trading Activity
Volume28.76M
Value Traded1.46M
Bid$0.049 × 1,164,754
Ask$0.050 × 74,999
Performance
1 Day-1.92%
5 Day-87.09%
13 Week-87.09%
52 Week-83.28%
YTD-87.71%
Technical Indicators
RSI (14)17.48
50-Day SMA$0.362
200-Day SMA$0.297
Latest News
Hot Topics
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
3 min read
Biotechnology
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer
Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metastatic breast cancer. AIPAC-003 is evaluating the company’s soluble LAG-3 protein and first-in-class MHC Class II agonist known as eftilagimod alpha (efti) in combination with standard-of-care paclitaxel for the treatment […]
2 min read
